The Sofusa® Drug Delivery System, for which Sorrento Therapeutics use Obducat’s NIL technology to fabricate the nanotopography draped microneedles, was highlighted in Sorrento Therapeutics proprietary mRNA vaccine development program for COVID-19.
Sorrento Therapeutics, a biopharmaceutical company, reports positive initial result in dosing with the Sofusa® Lymphatic Drug Delivery Device. Sorrento Therapeutics use Obducat’s NIL technology to fabricate the nanotopography draped microneedles used in the Sofusa® Drug Delivery System.
Nanotechnology is about the ability to see and to control individual atoms and molecules. It is typically measured in nanometres and the technology can be applied across many fields such as chemistry, biology, physics, materials science and engineering.
Obducat is an innovative developer and world-leading supplier of micro-and nano lithography solutions. We supply the technology, products and processes used for advanced micro- and nanopatterning of surfaces.
Obducat receives order for an EITRE® 8 NIL-system and a resist processing system from Gusu Lab in China
OBDUCAT AB (publ) subsidiary Obducat Technologies AB and Obducat Europe GmbH, leading suppliers of lithography processing solutions and nanoimprint lithography (NIL) tools, have received orders from Gusu Lab in China, for the supply of a EITRE 8 NIL-system as well as a resist coating system. The order value amounts to approx. 4.0 million SEK. The…
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.